Halozyme to Acquire Elektrofi, Expanding Our Offerings in Innovative Drug Delivery and Strengthening Long-Term Growth into 2040sPRNewsWire • 10/01/25
Powell Warns of Valuation Risks: 5 High Earnings Yield Value PicksZacks Investment Research • 09/24/25
Halozyme Therapeutics (HALO) Is Up 2.63% in One Week: What You Should KnowZacks Investment Research • 09/19/25
5 High Earnings Yield Stocks to Buy Ahead of Potential Fed Rate CutsZacks Investment Research • 09/09/25
Halozyme Therapeutics, Inc. (HALO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25
Bet on These 3 Stocks With Upgraded Broker Ratings for Robust ReturnsZacks Investment Research • 09/05/25
Halozyme Therapeutics, Inc. (HALO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Prepared Remarks TranscriptSeeking Alpha • 09/04/25
Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 09/03/25
After Golden Cross, Halozyme Therapeutics (HALO)'s Technical Outlook is BrightZacks Investment Research • 08/08/25
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG SECOND QUARTER 2025 RESULTSPRNewsWire • 08/05/25
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 07/29/25